Martingale Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,168
Closed -$37.2K 818
2025
Q2
$37.2K Buy
+10,168
New +$37.9K ﹤0.01% 779

Other funds holding ORGO

Martingale Asset Management's ORGO Position: Q3 2025 in Review

Martingale Asset Management sold out of Organogenesis Holdings (ORGO) in Q3 2025, closing a stake of 10,168 shares — an estimated $37.2K sold.

Martingale Asset Management first reported a position in ORGO in Q2 2025 and held it in 1 quarter. The position peaked at $37.2K in Q2 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q3 2025.

  • Martingale Asset Management reported no remaining Organogenesis Holdings position as of Q3 2025 after selling out during the quarter.
  • Martingale Asset Management sold 10,168 Organogenesis Holdings shares in Q3 2025, an estimated $37.2K.
  • Martingale Asset Management first reported a position in Organogenesis Holdings in Q2 2025 and held it in 1 quarter.
  • Martingale Asset Management's Organogenesis Holdings position peaked at $37.2K in Q2 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2025.

Based on Martingale Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.